Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Were you diagnosed with diabetes before taking Tequin?

Were you diagnosed with diabetes after taking Tequin?

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.



Tequin Side Effects May Result In Diabetes Lawsuits

Tequin | Lawsuits, Lawyers | Side Effects: Diabetes, Fatal Blood Sugar Abnormalities, Blood-Sugar Problem

Tequin to be Pulled from the Market

On May 1, 2006, Bristol-Myers Squibb stated that it will cease making and selling its antibiotic Tequin. Tequin has been linked to serious cases of diabetes and other potentially fatal blood sugar abnormalities. According to a Canadian study that was supposed to appear in the New England Journal of Medicine in March, Tequin users had 17 times greater risk of developing serious diabetes and 4 times greater risk of being hospitalized with low blood sugar complications than patients using other antibiotics. Tequin (generic: gatifloxacin) received FDA approval in 1999.  Consumer group Public Citizen stated that there have been 388 patients with blood-sugar irregularities linked with Tequin since January 1, 2000.  Those cases included 20 deaths and 159 hospitalizations. The consumer group and various physicians called for the drug's withdrawal, claiming it carries great health risks but few benefits over similar drugs.

Canadian Study

In March, 2006 the results of a Canadian study were released which showed that Tequin was linked to serious cases of diabetes and other blood sugar disorders. These results were set to appear in the March 30, 2006 New England Journal of Medicine but were released early due to the life threatening nature of the side effects. Based on the study's alarming findings, the author, Dr. David Juurlink of the Sunnybrook and Women's College Health Sciences Center in Toronto, questioned whether the drug should be immediately removed from the market. Other prominent physicians believed that a black box warning should be added to Tequin's warning label.

Warning for Diabetics May Apply to Anyone Taking Tequin

In early 2006, Bristol Myers Squibb and the FDA added a warning to the drug's label notifying diabetics not to take Tequin. However, the study's author said the  blood-sugar problem can happen to anybody whether they have diabetes or not, and it usually occurs within a few days of taking the drug. The risk of the drug might be even greater than the study revealed because it was only based on hospital data. If a patient suffered these side effects but wasn't hospitalized, or died, they would not have been included in the study data.

About Tequin

Tequin is an antibiotic that is commonly used to treat adults with lung, sinus and urinary tract infections as well as certain sexually transmitted diseases. Tequin is an antibiotic in the class of drugs called fluoroquinolones, which also contains Cipro, Levaquin and Avelox. This recent study indicates that the risk of diabetes is specific to Tequin and is not a problem with the entire class of drugs. However, the entire class of drugs has been linked to tendon ruptures. Last year Tequin had worldwide sales of $150 million, including $100 million in the United States.

Legal Help for Tequin Users

If you or a loved one took Tequin and suffered from diabetes, hyperglycemia, hypoglycemia, or other blood sugar side effects, please fill out the form at the right for a free case evaluation by a qualified defective drugs attorney or call us anytime at 1-800-YOURLAWYER (1-800-968-7529).


TequinRSS Feed

Double Vision Possible Fluoroquinolone Side Effect

Sep 9, 2009 | Parker Waichman LLP
Fluoroquinolones, a class of antibiotics that includes Levaquin and Cipro, may cause double vision in some patients, according to a new  study.  The study appears in the September issue of Ophthalmology.In conducting this latest fluoroquinolone study, researchers at Casey Eye Institute at the Oregon Health and Science University in Portland analyzed all eye-related adverse event associated with the drugs that had been reported in international databases and the medical literature...

Antibiotics Most Likely to Cause Drug Induced Liver Injury

Dec 2, 2008 | Parker Waichman LLP
Antibiotics are the drugs most responsible for the occurrence of drug induced liver injury (DILI), a new study has found.  According to a  press release announcing the study, DILI is the most frequent adverse drug-related event leading to abandonment of potentially promising new drug candidates during clinical trials and development.DILI is the most common cause of death from acute liver failure and accounts for approximately 13 percent of  all such cases in the U.S.  It is...

Tequin Patient Develops Severe Diabetes, Sues Bristol-Meyers Squibb

Aug 1, 2007 | Parker Waichman LLP
A Missouri man who took the antibiotic Tequin is suing Bristol-Meyers Squibb and Schering Corporation for blood sugar problems he developed while taking the drug.  Patrick Bills alleges that he developed both hyperglycemia and new onset diabetes while taking Tequin for a skin infection.Tequin, a once-popular antibiotic, was introduced by Bristol Myers Squibb in 1999 to treat bacterial infections like pneumonia, bronchitis, urinary tract infections and sinusitis.  By 2001, 3.3 million...

FDA Asked to Ban Antibiotic Tequin

May 2, 2006 | Consumer Affairs
Public Citizen has petitioned the U.S. Food and Drug Administration (FDA) to ban the antibiotic Tequin because it is linked to blood sugar abnormalities and has caused deaths and hospitalizations. The drug, made by Bristol-Myers Squibb and approved for use in the United States in December 1999, has been linked to severe cases of low blood sugar and high blood sugar. The company is withdrawing the drug but thousands of doses remain in the supply chain. The drug is used to treat chronic...

Company abandons antibiotic linked to blood sugar problems

May 2, 2006 | CBC News
An antibiotic linked to serious blood-sugar complications has been pulled from the market in Canada and the U.S. Bristol-Myers Squibb Co. said Tuesday it will no longer make or sell the antibiotic Tequin, also known as gatifloxacin. The antibiotic Tequin treats infections in the respiratory and urinary tracts, bladder infections, and sexually transmitted diseases. However, current stocks of the drug are not being recalled, a spokesman for Bristol-Myers Squibb said. Anyone taking the drug...

More Tequin News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo